Search - tctmd.com

Displaying 441 - 460 of 3000

Sort: Relevancy | Date

News Conference News CRT 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

L.A. McKeown

March 19, 2024

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Caitlin E. Cox

March 18, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

New Advice Released on Advanced Imaging for Evaluation of CV Infections

Todd Neale

March 14, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

Podcast TCTMD Talking Points

The ARIE-HM3 Trial

March 13, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Presenter: Stavros G. Drakos

March 05, 2024

Presentation THT Abstracts 2024

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

March 05, 2024

Presentation THT 2024

How to Manage VT in Advanced HF and Post-LVAD Patients

Presenter: Jakub Sroubek

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Advertisement

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

New Advice Released on Advanced Imaging for Evaluation of CV Infections

Cognitive Impairment a Real Concern in HF Patients: HFSA

Physicians (Mostly) Negative on Private Equity in Healthcare

The ARIE-HM3 Trial

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Patients With CKD Remain Underrepresented in Trials of CV Meds

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

How to Manage VT in Advanced HF and Post-LVAD Patients

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content